TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CTOR

Citius Oncology, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

1.00$ -8.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CTOR
Line item 2021 2022 2023 2024 2025
+11.8% +76.7% +19.6%
+187.5% +41.8% +151.1%
-90.8% -99.6% +3,504,282.1%
+3,504,282.1%
+169.5%
+0.0% +83.5% +0.0%
+245.6% +72.2% +46.7%
+260.0% +55.4% +51.3%
+1,296.4% +187.9% +256.6%
+0.0%
-29.6% +80.7% -2.8%
+10.8% -0.8% -20.0% +2.4%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?